The convenience of family and community health nurses-led care for the treatment of rheumatic diseases with biological or targeted synthetic disease-modifying antirheumatic drugs. The experience of Valcamonica, Italy
Reumatismo · 2026
DOI: 10.4081/reumatismo.2026.1925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reumatismo, 2026. Verfasst von Ambra Mosconi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Territory District, ASST of Valcamonica, Breno (BS). Hauptthemen laut MEDLINE: Antirheumatic Agents, Rheumatic Diseases, Nurses, Community Health, Nurse's Role. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To investigate the role of family and community health nurses (FCHNs) in monitoring the safety and efficacy of biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) in chronic rheumatic diseases.
Methods
We followed 141 consecutive patients (median age 59 years; 69% female) with autoimmune diseases, mainly rheumatoid arthritis (RA; 46.1%) and spondyloarthritis (SpA; 46.8%), receiving bDMARDs or tsDMARDs from January 2024 to March 2025 (“IFER” protocol). FCHNs monitored treatment safety and efficacy using patient-reported outcomes every 2 months and composite disease activity indices at 6 and 12 months. Patients with adverse events, disease complications, or high disease activity were referred to the rheumatologist for treatment reassessment. Major adverse events, healthcare costs, and rheumatology visits were compared with historical data from 2021 to 2023.
Results
No significant difference in major adverse events was observed compared with previous years (deaths: 2 vs. 3; hospitalizations: 9 vs. 25; emergency room visits: 3 vs. 12; p=ns). Agreement between rheumatologists and FCHNs in disease activity assessment was moderate overall (Cohen’s κ=0.54±0.06), good in RA (κ=0.65±0.08), and poor in SpA (κ=0.29±0.10). Per-capita annual costs decreased significantly (€5164 vs. €4590; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Territory District, ASST of Valcamonica, Breno (BS).
- Hospital Pharmacia, ASST of Valcamonica, Esine (BS).
- Rheumatology Unit, Department of Medical Sciences, ASST of Valcamonica, Edolo (BS).
- Internal Medicine, Department of Medical Sciences, ASST of Valcamonica, Esine (BS).
- Medicine Unit of Edolo, Department of Medical Sciences, ASST of Valcamonica, Edolo (BS).
- Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia.
Zitieren
APA
Mosconi, A., Macri, G., Pelamatti, E., Inverardi, F., Richini, R., Ghirardelli, M. L., Furloni, R., Strazzeri, R. D., Rizzi, C. S., Galbassini, G., Laffranchini, P., Cincera, R., Airò, P., Franceschini, F., & Scarsi, M. (2026). The convenience of family and community health nurses-led care for the treatment of rheumatic diseases with biological or targeted synthetic disease-modifying antirheumatic drugs. The experience of Valcamonica, Italy. Reumatismo. https://doi.org/10.4081/reumatismo.2026.1925
Vancouver
Mosconi A, Macri G, Pelamatti E, Inverardi F, Richini R, Ghirardelli ML, et al. The convenience of family and community health nurses-led care for the treatment of rheumatic diseases with biological or targeted synthetic disease-modifying antirheumatic drugs. The experience of Valcamonica, Italy. Reumatismo. 2026. doi:10.4081/reumatismo.2026.1925
BibTeX
@article{Mosconi2026,
author = {Mosconi, Ambra and Macri, Giacomina and Pelamatti, Elisa and Inverardi, Flora and Richini, Renza and Ghirardelli, Maria Laura and Furloni, Roberto and Strazzeri, Roberto Domenico and Rizzi, Carmela Stefania and Galbassini, Gloria and Laffranchini, Patrizia and Cincera, Roberto and Airò, Paolo and Franceschini, Franco and Scarsi, Mirko},
title = {The convenience of family and community health nurses-led care for the treatment of rheumatic diseases with biological or targeted synthetic disease-modifying antirheumatic drugs. The experience of Valcamonica, Italy},
journal = {Reumatismo},
year = {2026},
doi = {10.4081/reumatismo.2026.1925}
}
EUVIMED